COVID-19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population- and Registry-Based Study

被引:17
|
作者
Vrdoljak, Eduard [1 ]
Balja, Melita Peric [2 ]
Marusic, Zlatko [3 ]
Avirovic, Manuela [4 ]
Blazicevic, Valerija [6 ]
Tomasovic, Cedna [8 ]
Cerina, Dora [1 ]
Bajic, Zarko [9 ]
Mise, Branka Petric [1 ]
Lovasic, Ingrid Belac [5 ]
Flam, Josipa [7 ]
Tomic, Snjezana [10 ]
机构
[1] Univ Split, Sch Med, Clin Hosp Ctr Split, Dept Oncol, Spinciceva 1, HR-21000 Split, Croatia
[2] Clin Hosp Ctr Sisters Mercy, Dept Pathol, Zagreb, Croatia
[3] Clin Hosp Ctr Zagreb, Dept Pathol, Zagreb, Croatia
[4] Clin Hosp Ctr Rijeka, Dept Pathol, Rijeka, Croatia
[5] Clin Hosp Ctr Rijeka, Dept Oncol, Rijeka, Croatia
[6] Clin Hosp Ctr Osijek, Dept Pathol, Osijek, Croatia
[7] Clin Hosp Ctr Osijek, Dept Oncol, Osijek, Croatia
[8] Clin Hosp Dubrava, Dept Pathol, Zagreb, Croatia
[9] Univ Psychiat Hosp Sveti Ivan, Res Unit Dr Mirko Grmek, Zagreb, Croatia
[10] Univ Hosp Split, Dept Pathol, Split, Croatia
来源
ONCOLOGIST | 2021年 / 26卷 / 07期
关键词
COVID-19; SARS-CoV-2; Coronavirus; Pandemic; Breast cancer; Lockdown; SURVIVAL; IMPACT; DELAY; STAGE;
D O I
10.1002/onco.13791
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Our objective was to assess the effects of COVID-19 antiepidemic measures and subsequent changes in the function of the health care system on the number of newly diagnosed breast cancers in the Republic of Croatia. Subjects, Materials, and Methods We performed a retrospective, population- and registry-based study during 2020. The comparator was the number of patients newly diagnosed with breast cancer during 2017, 2018, and 2019. The outcome was the change in number of newly diagnosed breast cancer cases. Results The average monthly percent change after the initial lockdown measures were introduced was -11.0% (95% confidence interval - 22.0% to 1.5%), resulting in a 24% reduction of the newly diagnosed breast cancer cases in Croatia during April, May, and June compared with the same period of 2019. However, during 2020, only 1% fewer new cases were detected than in 2019, or 6% fewer than what would be expected based on the linear trend during 2017-2019. Conclusion It seems that national health care system measures for controlling the spread of COVID-19 had a detrimental effect on the number of newly diagnosed breast cancer cases in Croatia during the first lockdown. As it is not plausible to expect an epidemiological change to occur at the same time, this may result in later diagnosis, later initiation of treatment, and less favorable outcomes in the future. However, the effect weakened after the first lockdown and COVID-19 control measures were relaxed, and it has not reoccurred during the second COVID-19 wave. Although the COVID-19 lockdown affected the number of newly diagnosed breast cancers, the oncology health care system has shown resilience and compensated for these effects by the end of 2020. Implications for Practice It is possible to compensate for the adverse effects of COVID-19 pandemic control measures on breast cancer diagnosis relatively promptly, and it is of crucial importance to do it as soon as possible. Moreover, as shown by this study's results on the number of newly diagnosed breast cancer cases during the second wave of the pandemic, these adverse effects are preventable to a non-negligible extent.
引用
收藏
页码:E1156 / E1160
页数:5
相关论文
共 50 条
  • [1] COVID-19 and Cancer A Review of the Registry-Based Pandemic Response
    Desai, Aakash
    Mohammed, Turab J.
    Duma, Narjust
    Garassino, Marina C.
    Hicks, Lisa K.
    Kuderer, Nicole M.
    Lyman, Gary H.
    Mishra, Sanjay
    Pinato, David J.
    Rini, Brian I.
    Peters, Solange
    Warner, Jeremy L.
    Whisenant, Jennifer G.
    Wood, William A.
    Thompson, Michael A.
    [J]. JAMA ONCOLOGY, 2021, 7 (12) : 1882 - 1890
  • [2] Impact of the COVID-19 pandemic on population-based cancer registry
    Soerjomataram, Isabelle
    Bardot, Aude
    Aitken, Joanne
    Pineros, Marion
    Znaor, Ariana
    Steliarova-Foucher, Eva
    Kohler, Betsy
    Bettio, Manola
    Matsuda, Tomohiro
    de Camargo Cancela, Marianna
    Mery, Les
    Bray, Freddie
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (02) : 273 - 278
  • [3] COVID-19 Pandemic Effects on Cervical Cancer Diagnosis and Management: A Population-Based Study in Romania
    Popescu, Alin
    Craina, Marius
    Pantea, Stelian
    Pirvu, Catalin
    Chiriac, Veronica Daniela
    Marincu, Iosif
    Bratosin, Felix
    Bogdan, Iulia
    Hosin, Samer
    Citu, Cosmin
    Bernad, Elena
    Neamtu, Radu
    Dumitru, Catalin
    Mocanu, Adelina Geanina
    Avram, Claudiu
    Gluhovschi, Adrian
    [J]. DIAGNOSTICS, 2022, 12 (04)
  • [4] The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study
    Castellano, Cecilia A.
    Sun, Tianyi
    Ravindranathan, Deepak
    Hwang, Clara
    Balanchivadze, Nino
    Singh, Sunny R. K.
    Griffiths, Elizabeth A.
    Puzanov, Igor
    Ruiz-Garcia, Erika
    Vilar-Compte, Diana
    Cardenas-Delgado, Ana I.
    McKay, Rana R.
    Nonato, Taylor K.
    Ajmera, Archana
    Yu, Peter P.
    Nadkarni, Rajani
    O'Connor, Timothy E.
    Berg, Stephanie
    Ma, Kim
    Farmakiotis, Dimitrios
    Vieira, Kendra
    Arvanitis, Panos
    Saliby, Renee M.
    Labaki, Chris
    El Zarif, Talal
    Wise-Draper, Trisha M.
    Zamulko, Olga
    Li, Ningjing
    Bodin, Brianne E.
    Accordino, Melissa K.
    Ingham, Matthew
    Joshi, Monika
    Polimera, Hyma V.
    Fecher, Leslie A.
    Friese, Christopher R.
    Yoon, James J.
    Mavromatis, Blanche H.
    Brown, Jacqueline T.
    Russell, Karen
    Nanchal, Rahul
    Singh, Harpreet
    Tachiki, Lisa
    Moria, Feras A.
    Nagaraj, Gayathri
    Cortez, Kimberly
    Abbasi, Saqib H.
    Wulff-Burchfield, Elizabeth M.
    Puc, Matthew
    Weissmann, Lisa B.
    Bhatt, Padmanabh S.
    [J]. CANCER, 2024, 130 (12) : 2191 - 2204
  • [5] Diagnosis and treatment of breast cancer in Denmark during the COVID-19 pandemic: a nationwide population-based study
    Ibfelt, Else Helene
    Jensen, Henry
    Offersen, Birgitte Vrou
    Hansen, Maiken Bang
    Moller, Henrik
    Christiansen, Peer
    Olesen, Tina Bech
    [J]. ACTA ONCOLOGICA, 2023, : 1749 - 1756
  • [6] Diagnosis and treatment of digestive cancers during COVID-19 in Japan: A Cancer Registry-based Study on the Impact of COVID-19 on Cancer Care in Osaka (CanReCO)
    Saito, Mari Kajiwara
    Morishima, Toshitaka
    Ma, Chaochen
    Koyama, Shihoko
    Miyashiro, Isao
    [J]. PLOS ONE, 2022, 17 (09):
  • [7] Impact of the COVID-19 pandemic on skin cancer diagnosis: A population-based study
    Asai, Yuka
    Nguyen, Paul
    Hanna, Timothy P.
    [J]. PLOS ONE, 2021, 16 (03):
  • [8] The COVID-19 Pandemic Impact on Breast Cancer Diagnosis: A Retrospective Study
    Negrao, Erika Marina Solla
    Cabello, Cesar
    Conz, Livia
    Mauad, Edmundo Carvalho
    Zeferino, Luiz Carlos
    Vale, Diama Bhadra
    [J]. REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2022, 44 (09): : 871 - 877
  • [9] Anaphylaxis After COVID-19 Vaccination: A Registry-Based Study
    Jaggers, Jordon
    Samarakoon, Upeka
    Fu, Xiaoqing
    Gonzalez-Estrada, Alexei
    Anvari, Sara
    Tarun, Shwetabh
    Chong, Hey
    Van Meerbeke, Sara
    Petrov, Andrej
    Milkovich, Linette
    Hartigan, Elizabeth
    Chow, Timothy
    Blumenthal, Kimberly
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB313 - AB313
  • [10] Management of ocrelizumab in MS patients during the COVID-19 pandemic: an observational registry-based study
    Bisecco, A.
    Matrone, F.
    Capobianco, M.
    De Luca, G.
    Filippi, M.
    Granella, F.
    Lus, G.
    Marfia, G. A.
    Mirabella, M.
    Patti, F.
    Trojano, M.
    Mascolo, A.
    Copetti, M.
    Tedeschi, G.
    Gallo, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 652 - 653